GBLEF yields 9661.84% · PFE yields 6.13%● Live data
📍 GBLEF pulled ahead of the other in Year 1
Combined, GBLEF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GBLEF + PFE for your $10,000?
Global Energy Metals Corporation engages in the exploration for resource properties in Canada, Australia, and the United States. It explores for cobalt, copper, nickel, gold, silver, and base metal deposits. The company holds interests in the Werner Lake property located in Kenora, Ontario; the Millennium and Mount Isa projects situated in Mount Isa, Queensland; and the Lovelock Mine and Treasure Box projects in Churchill County, Nevada. It also holds interest in the Rana nickel-copper-cobalt project, which include the Bruvann nickel mine located in Northern Norway. In addition, the company holds interest in the Monument Peak copper-silver-gold property covering an area of approximately 691 hectares located in the Idaho; and the Chance Lake property comprising 16 contiguous claims, which covers approximately 777.7 hectares; and the Amiral property comprising 40 contiguous mineral claims covering an area of approximately 2,162.5 hectares located in Quebec, Canada. Global Energy Metals Corporation was incorporated in 2015 and is headquartered in Vancouver, Canada.
Full GBLEF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.